Trials / Unknown
UnknownNCT02504437
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Academy Military Medical Science, China · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the present study is to evaluate the efficacy of the preconditioned autologous bone marrow mesenchymal stem cells for patients with ischemic heart diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BMMSCs |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-07-22
- Last updated
- 2015-07-22
Source: ClinicalTrials.gov record NCT02504437. Inclusion in this directory is not an endorsement.